Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by ORBnewbieon Feb 17, 2015 12:44pm
164 Views
Post# 23436123

RE:RE:RE:RE:Handling of the news release

RE:RE:RE:RE:Handling of the news release"It's in the presentation on their website dated 2/1/2015. Here's the link: https://www.telestatherapeutics.com/cms/phpjpCpxr.pdf"

That kind of highlights my point then loveshack. They had a full market analysis done and it concluded that the market fo MCNA was twice as big as previously thought and would reach 400M in the U.S alone. Yet the only place that information was initially released was buried in a 30 page document only available on their website. What good does that do any shareholder? They announced in December that a third party market analysis was due to be released in the weeks to come and that's what we got? 
Money talks. If they'd made a bigger deal out of this in an attempt to get the attention of the public we may have seen a nice little jump in our sp. Poor marketing. The only way a little company like this is going to improve value for shareholders before FDA approval is to take advantage of every piece of positive news they get and shout it to the world. Not bury it in a 30 page report that nobody besides current shareholders are going to read. 
<< Previous
Bullboard Posts
Next >>